51407-853-30ol (Erythromycin DR Tablets)
Erythromycin Tablet, Delayed Release
Product Images NDC 51407-853
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 51407-853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
51407-854-30ol (Erythromycin DR Tablets)
The text provided appears to be a description of Erythromycin Delayed-Release Tablets, USP. Each tablet contains 500 mg of Erythromycin as the free base. The dosage information is not available in the text, but it suggests referring to the accompanying Prescribing Information. The tablets are to be dispensed in a USP tight container and kept tightly closed. It is important to keep this medication out of the reach of children and not accept it if the seal over the bottle opening is broken or missing. The dosage may be administered without regard to meals. The recommended storage temperature is between 20°C - 25°C (68°F - 77°F), with permitted excursions between 15°C - 30°C (59°F - 86°F) according to USP Controlled Room Temperature guidelines. The product is marketed by GSMS, Incorporated in Camarillo, CA, USA. However, the -generated text seems incomplete and the description may not be entirely accurate.*
Chemical-structure (Chemical Structure)
Torrentlogo (Torrentlogo)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
